Alpha Omega for Medical Sciences Research & Development Co.
Translating innovative science into effective therapeutic solutions with a focus on oncology research.
Science-Based Pharmaceutical Development
Alpha Omega for Medical Sciences Research & Development Co. is dedicated to biomedical research and pharmaceutical development, with a specific focus on oncology and translational science.
Through strategic global partnerships and rigorous methodology, we move novel compounds from early discovery through preclinical development toward clinical readiness.
- Oncology Therapy
- Preclinical Research
- Pharmaceutical Development
- Formulation Science
Where We Focus
Cancer Drug Development
Development of novel compounds targeting oncological conditions through preclinical research and rigorous formulation.
Toe Nail Fungus Treatment Development
Targeted antifungal formulations engineered to address onychomycosis with improved efficacy and patient tolerability.
Sore Throat Gargle Development
Therapeutic gargle formulations designed to relieve symptoms and address the underlying causes of pharyngeal infections.
Preclinical Research
Rigorous preclinical pipelines covering compound screening, efficacy modeling, and safety profiling ahead of clinical readiness.
Formulation & Translational Science
Bridging discovery to therapy through advanced formulation work and translational research focused on real clinical impact.
What Sets Us Apart
Charles River Laboratories Partnership
Partnership with a globally recognized contract research organization providing world-class preclinical research infrastructure and expertise.
KFAS Research Grant Recipient
Recognized and funded by the Kuwait Foundation for the Advancement of Sciences for our research programs.
Research-Driven, Science-First
Every decision is built on data, evidence, and rigorous scientific methodology.
Translational Science Mindset
Connecting discovery with therapeutic application, focusing on real clinical and patient impact.
Strategic Partnerships



Our objective is to advance innovative therapies while contributing to Kuwait's life sciences ecosystem.
Contributing to Kuwait's growing life sciences ecosystem through science-driven development and strategic international collaboration.
